Daniel Oder - Concepedia

Author

Daniel Oder

Universitätsklinikum Würzburg ORCID

Also Known As

D Oder, D. Oder, Daniel Oder, Oder, Daniel

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Universitätsklinikum Würzburg Comprehensive Cancer Center Mainfranken St Bartholomew's Hospital Amsterdam UMC Location University of Amsterdam University College London

About

Daniel Oder is an author at Universitätsklinikum Würzburg specializing in nephrology, medicine, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	103
2	Nephrology	1	1	103
3	Pathology	1	1	103
4	Biomarkers	1	1	103
5	Cardiology	1	1	103

Daniel Oder

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study Maarten Arends, Christoph Wanner, Derralynn Hughes, Journal of the American Society of Nephrology	2016	406
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study Maarten Arends, Marieke Biegstraaten, Christoph Wanner, Journal of Medical Genetics	2018	119
Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement Nicolas Guérard, Daniel Oder, Peter Nordbeck, Clinical Pharmacology & Therapeutics	2017	106
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors Maarten Arends, Marieke Biegstraaten, Derralynn Hughes, PLoS ONE Retrospective StudyCardiomyopathyUrologyFabry DiseaseDisease Progression	2017	103
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year Jonas Müntze, Daniel Gensler, Octavian Maniuc, Clinical Pharmacology & Therapeutics	2018	91
Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y Daniel Oder, Nurcan Üçeyler, Dan Liu, BMJ Open	2016	55
Impact of immunosuppressive therapy on therapy‐neutralizing antibodies in transplanted patients with Fabry disease Malte Lenders, Daniel Oder, Albina Nowak, Journal of Internal Medicine	2017	43
α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease Daniel Oder, Dan Liu, Kai Hu, Circulation Cardiovascular Genetics	2017	38
Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease Dan Liu, Daniel Oder, Tim Salinger, Open Heart	2018	26
Characterization of vertigo and hearing loss in patients with Fabry disease M Köping, Wafaa Shehata-Dieler, Dieter Schneider, Orphanet Journal of Rare Diseases	2018	25

Page 1